Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A preclinical safety evaluation reported no minimal toxic or lethal doses in animals
Graphical abstract Similar content being viewed by others Introduction Diseases of the central nervous system (CNS), including Alzheimer's disease, Parkinson's disease, stroke, and brain tumors, have affected the normal lives of an increasing number of people worldwide in recent years[1,2,3]
demonstrated the potential of aptamers in cell-specific targeting by using the AS-1411 G-enriched aptamer of DNA to direct CX-5461 loaded mesoporous silica nanoparticles to penetrate specifically to tumor cells through binding with nucleoli, a highly expressed protein on the tumor cell surface [229]
Afr J Mar Sci 33:239246
